Lipocine Inc.

The momentum for this stock is not very good. Lipocine Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in Lipocine Inc..

Lipocine, Inc. operates as a pharmaceutical company, which engages in the research and development o...

News

Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek

PR Newswire Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek Lipocine Announces Phase 2 Data on LPCN 2401 to be Presented at ObesityWeek PR Newswire SALT LAKE CITY, Sept. 5, 2024 Study...\n more…

StockNews.com Lowers Lipocine (NASDAQ:LPCN) to Hold

Ticker Report Lipocine (NASDAQ:LPCN - Get Free Report) was downgraded by equities researchers at StockNews.com from a "buy" rating to a "hold" rating in a research report issued to clients and investors on Friday...\n more…

Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference

PR Newswire Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference Lipocine to Present at H.C. Wainwright 26th Annual Global Investment Conference PR Newswire SALT LAKE CITY, Aug. 27...\n more…

StockNews.com Lowers Lipocine (NASDAQ:LPCN) to Hold

Ticker Report Lipocine (NASDAQ:LPCN - Get Free Report) was downgraded by investment analysts at StockNews.com from a "buy" rating to a "hold" rating in a research note issued to investors on Saturday. Lipocine...\n more…

Lipocine (NASDAQ:LPCN) Upgraded to "Buy" by StockNews.com

Zolmax StockNews.com upgraded shares of Lipocine (NASDAQ:LPCN - Free Report) from a hold rating to a buy rating in a research report sent to investors on Friday.\nLipocine Stock Down 9.1 %\nNASDAQ:LPCN opened...\n more…

LPCN Stock Earnings: Lipocine Beats EPS, Misses Revenue for Q2 2024

InvestorPlace InvestorPlace - Stock Market News, Stock Advice & Trading Tips\nLPCN stock results show that Lipocine beat analyst estimates for earnings per share but missed on revenue for the second quarter of...\n more…